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Background: Intake of high-fat diet is associated with increased non-alcoholic fatty liver disease (NAFLD). Hepatic
lipid accumulation and oxidative stress are key pathophysiological mechanisms in NAFLD. Both flaxseed oil (FO)
and α-lipoic acid (LA) exert potential benefit to NAFLD. The aim of this study was to determine the effect of the
combination of FO and LA on hepatic lipid accumulation and oxidative stress in rats induced by high-fat diet.
Methods: LA was dissolved in flaxseed oil to a final concentration of 8 g/kg (FO + LA). The rodent diet contained 20%
fat. One-fifth of the fat was soybean oil and the others were lard (control group), or 75% lard and 25% FO + LA (L-FO +
LA group), or 50% lard and 50% FO + LA (M-FO + LA group), or FO + LA (H-FO + LA group). Male Sprague–Dawley rats
were fed for 10 weeks and then killed for liver collection.
Results: Intake of high-fat lard caused a significant hepatic steatosis. Replacement with FO + LA was effective in
reducing steatosis as well as total triglyceride and total cholesterol contents in liver. The combination of FO and LA also
significantly elevated hepatic antioxidant defense capacities, as evaluated by the remarkable increase in the activities of
SOD, CAT and GPx as well as the level of GSH, and the significant decline in lipid peroxidation.
Conclusion: The combination of FO and LA may contribute to prevent fatty livers such as NAFLD by ameliorating
hepatic lipid accumulation and oxidative stress.
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Nonalcoholic fatty liver disease (NAFLD) is a clinico-
pathological term that encompasses a broad spectrum
ranging from benign hepatic steatosis to cirrhosis. It is
the most common liver disease and now recognized as a
major public health problem in contemporary society
around the world [1,2]. High-fat diet is the most com-
mon cause of NAFLD [3] because chronic consumption
of this type of diet leads to obesity, abnormalities of lipid
metabolism and insulin resistance, all of which have
been reported to be linked to NAFLD [4]. Regardless of* Correspondence: fhhuang@foxmail.com
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reproduction in any medium, provided the oretiology of NAFLD, lipid accumulation and oxidative
stress are two requisite for this disease progression [5].
Flaxseed oil (FO) is a particularly rich source of α-
linolenic acid (LNA) with concentrations ranging from
approximately 40% to 60% [6]. As a nutritionally essen-
tial polyunsaturated fatty acid (PUFA), LNA can act as
the precursor of longer chain n-3 PUFA (EPA and DHA)
or compete with linoleic acid to reduce arachidonic acid
content or direct interaction with ion channels and nu-
clear receptors, and thus may exert numerous beneficial
effects in the human body, such as antiarrhythmic,
antiinflammatory and neuroprotective functions as well
as accelerating brain growth in preterm and neonates
[7]. Recently, LNA has been reported to lower serum
lipids, liver size and hepatic lipids contents and thus at-
tenuate NAFLD [8]. However, since LNA is highly sus-
ceptible to oxidation, FO addition may result in aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tissues [9], which may have an adverse effect on
hepatoprotection.
α-lipoic acid (LA), also referred to as thioctic acid, is
a disulfide compound that is found naturally in mito-
chondria as the coenzyme for pyruvate dehydrogenase
and α-ketoglutarate thus serves a critical role in mito-
chondrial energy metabolism. Although orally supplied
LA may not be used as a metabolic cofactor, there is
a unique set of biochemical activities with potential
pharmacotherapeutic value against a host of pathophysi-
ologic insults [10]. For example, LA has gained consider-
able attention as an excellent antioxidant to reduce
oxidative stress [11-13]. Further, LA is fat- and water-
soluble, which makes it effective against a broader range
of free radicals. It has also been demonstrated recently
that LA has ability to prevent hepatic steatosis in rat fed
a long-term high-fat diet [14]. These beneficial effects
make LA possess the potential abilities to improve
NAFLD [15].
The combination of FO and LA has been demon-
strated to reduce atherosclerosis risk in our previous
study [16]. The purpose of the present study was to de-
termine whether the combination of FO and LA is able
to decrease hepatic lipid accumulation and oxidative
stress in rats fed a high-fat diet.Materials and methods
Chemical sources
Commercial deodorized lard and soybean oil (food
grade) was purchased from a local supermarket. The
flaxseed oil (food grade) was obtained from
Caoyuankangshen Food Co., Ltd (Inner Mongolia,
China). The fatty acids compositions of these experi-
mental oils are shown in Table 1. LA ((±)-α-Lipoic acid)
was purchased from Sigma-Aldrich (St. Louis, MO,Table 1 Fatty acid composition of the experimental oils
(%)1
Fatty acid Lard Soybean oil Flaxseed oil
C14 : 0 1.36 0.078 ND2
C16 : 0 29.32 10.77 6.13
C16 : 1 2.21 0.05 ND
C18 : 0 13.31 4.00 3.67
C18 : 1 42.81 24.77 22.49
C18 : 2 9.67 52.62 14.86
C18 : 3 0.27 5.94 52.84
C20 : 0 0.58 0.36 ND
C20 : 1 0.47 0.29 ND
C22 : 0 ND 0.38 ND
1 Values given in this table are the means of three determinations.
2 ND = Not detected.USA) and was dissolved in flaxseed oil to a final concen-
tration of 8 g/kg (FO + LA) when used.Animals and diets
The experiment was conducted with 40 male Sprague–
Dawley rats (initially weighing 150–170 g). The animals
were housed individually and maintained at a controlled
ambient temperature (24 ± 1°C) under diurnal conditions
(light–dark: 08:00–20:00) with access to laboratory chow
and tap water ad libitum. After 1 week of acclimatization,
rats were randomly divided into control (CON) group and
three experimental groups (n =10 per group). All animals
were fed purified experimental diets which contained 35%
maize starch, 20% casein, 15% sucrose, 5% cellulose, 3.5%
mineral mixture (AIN-93M), 1% vitamin mixture (AIN-
93M), 0.3% DL-methionine, 0.2% choline bitartrate and
20% fat. One-fifth of the fat in the diet of each group was
provided by soybean oil to avoid essential fatty acid defi-
ciency, and the remaining were either lard (CON group),
or 75% lard and 25% FO+ LA (L-FO+ LA group), or 50%
lard and 50% FO+ LA (M-FO+ LA group), or FO + LA
(H-FO + LA group). Every week, all ingredients for the
purified diets were mixed, formed into a dough with puri-
fied water, rolled into pellets, sealed in air-tight plastic bags
under nitrogen gas and stored at −80°C until use. The food
in the animal cages was shaded from light and changed
every day. The animals were cared for in accordance with
the Guiding Principles in the Care and Use of Animals.
The experiment was approved by the Oil Crops Research
Institute Council on Animal Care Committee, Chinese
Academy of Agricultural Sciences.Tissue preparation
After 10 weeks of treatment, rats were fasted for 16 hours
and then killed under anaesthesia. Liver was rapidly dis-
sected, weighed, and a small piece of right liver lobe was
fixed in 4% paraformaldehyde for hematoxylin-eosine
staining. The remaining liver tissue was stored at −80°C
until analysis.Assay of liver antioxidant capacity and lipid peroxidation
Superoxide dismutases (SOD) activity was measured
according to the method of Kono [17]. Catalase (CAT)
activity was estimated basing on the method of Goth
[18]. Glutathione peroxidase (GPx) activity was mea-
sured by the method of Sazuka [19]. The glutathione
(GSH) content was determined by the method of Moron
[20]. Thiobarbituric acid reactive substances (TBARS)
level was estimated by the method of Buege and Aust
[21]. The detection procedure of these enzymes activities
has been described in detail in our previous report [22].
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The protein concentration was determined according to
the method of Lowry [23], using bovine serum albumin
(BSA) as standard.
Assay of liver lipid content
Lipids were extracted from 1 g liver with a mixture of
chloroform/methanol (2:1, v/v) by the method of Folch
[24]. Total triglyceride (TG) and total cholesterol (TC)
contents were measured with commercial kits
(Zhongsheng Beikong Biotech Company, China).
Statistical analyses
Results were expressed as mean ± SEM (standard error
of the mean). Statistical analysis were based on one-way
ANOVA, followed by the Fisher PLSD post hoc test if
the overall differences were significant. All statistical
analyses were performed using SPSS 13.0 statistical soft-
ware (SPSS Inc., Chicago, IL) and the limit of statistical
significance was set at p < 0.05.
Results
Food intake and body weight gain
No significant differences were observed in food intake or
in body weight gain among all groups. The body weight
was 162.1 ± 3.5, 163.7 ± 3.1, 160.5 ± 2.9, 162.9 ± 2.5 g at
the beginning and 454.0 ± 5.7, 446.8 ± 6.8, 437.1 ± 5.3,Figure 1 Liver histology after hematoxylin-eosine staining of liver sec
B: low contents of FO and LA combination group; C: middle contents of FO
combination group.443.2 ± 4.1 g at the end of the study for groups 1–4,
respectively.
Effects of FO and LA combination on liver morphology
As shown in Figure 1, HE–stained liver sections pointed
that the chronic high-fat lard diet induced significantly
increased macrovesicular steatosis. The circular lipid
droplets in both number and size were markedly re-
duced in L- and M-FO + LA livers and even not present
in H-FO + LA livers.
Effects of FO and LA combination on liver lipids content
There are not significant differences in liver weights among
all groups. However, consistent with histologic assessment,
and as can be seen from Figure 2, consumption of all three
doses of the combination of FO and LA significantly re-
duced hepatic lipids accumulation in contrast with the
high-fat lard diet, as evidenced by the markedly lower TG
and TC contents of livers in all FO + LA groups than in
control group.
Effects of FO and LA combination on liver antioxidative
capacity and lipid peroxidation
As shown in Figure 3, the activities of hepatic antioxidant
enzymes SOD and GPx were found to be statistically
elevated in M- and H- FO +LA animals, as compared to
high-fat lard animals. In addition, the CAT activities intions from a representative rat from each group. A: control group;






































Figure 2 Effects of FO and LA combination on hepatic TG and TC contents of rats fed a high-fat diet. CON: control group; L-. M- and H-
FO + LA: low, middle and high contents of FO and LA combination groups. Bars represent the mean ± SEM from 10 animals in each group. * p <
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Figure 3 Effects of FO and LA combination on the activities of antioxidant enzymes (SOD, GPx and CAT), the levels of GSH and the
contents of TBARS in liver of rats fed a high-fat diet. CON: control group; L-. M- and H- FO + LA: low, middle and high contents of FO and LA
combination groups. Bars represent the mean ± SEM from 10 animals in each group. ** p < 0.01 compared to the control group.
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control group. Compared with high-fat lard animals, the
levels of hepatic GSH were remarkably increased in M- and
H- FO+ LA administered rats. When plasma TBARS were
evaluated as the marker of lipid peroxidation, noticeable de-
clines in the TBARS contents were seen in the livers of M-
and H- FO+ LA groups.
Discussion
NAFLD covers a wide disease spectrum of liver pathology,
ranging from simple hepatic steatosis to nonalcoholic
steatohepatitis (NASH) and cirrhosis. The simple steatosis
is generally nonprogressive and reversible, while NASH is
increasingly recognized as a precursor to more severe liver
disease and may develop progressive hepatic fibrosis and
cirrhosis [2]. Although the pathogenesis of NAFLD has
not yet been fully elucidated, a most widely accepted
mechanism is the “two-hit” theory [5]. The “first hit” is
excessive hepatic fat accumulation, a process that is closely
linked with insulin resistance, and the “second hit” is
hepatocellular injury that results from oxidative stress.
High-fat diet can induce significant insulin resistance [25]
as well as oxidative stress in liver [26], and thus induces
the development of NAFLD [27].
Histologic evaluation is considered the “gold standard”
in evaluation of the presence and severity of NAFLD [28].
In the present study, the livers of the animals fed a high-
fat lard diet show noticeable hepatic steatosis. The com-
bination of FO + LA significantly improved the severe
hepatic steatosis, which meant that this combination can
protect against NAFLD. In parallel with the changes in
liver morphology, all of the L-, M- and H-FO + LA
reduced markedly both hepatic TG and TC contents. The
main components FO and LA in the combination were
both responsible for these beneficial changes. LNA has
been well established to be a natural ligand of peroxisome
proliferator-activated receptor-α (PPARα) [29] and shown
to bind and activate this key transcriptional regulator of
lipid metabolism, thereby increases the gene expression
and activities of enzymes involved in fatty acid oxidation
in the liver [30-33]. LNA itself is a better substrate for the
mitochondrial and peroxisomal β-oxidation pathways thus
stimulating oxidation of fatty acid in liver [33]. PPARγ,
another member of the PPAR family, is also a major tran-
scriptional regulator of lipid metabolism. FO has been
considered to induce a notable increase in the hepatic
mRNA expression of PPARγ which is negatively correlated
with hepatic lipid levels [34]. In addition, the depletion of
hepatic n-3 long-chain polyunsaturated fatty acids
(LCPUFA) is proposed to be a major factor contributed to
liver steatosis found in NAFLD [35]. As precursor fatty
acid of n-3 LCPUFA, LNA is able to increase significantly
EPA and DHA contents in hepatic membrane and thus
declines hepatic lipid levels [36]. Besides, in response toLNA rich FO, the higher activity of CYP7A1 results in a
higher cholesterol secretion into bile and then lowers the
intrahepatic pool of cholesterol [37]. Consistent with a
microarray analysis [38], LA has been reported to increase
mRNA level of PPARα [14], and as a consequence, up-
regulate the gene expression of several enzymes and pro-
teins involved in mitochondrial β-oxidation especially
long-chain acyl coenzyme A dehydrogenase (LCAD) [14],
a key enzymes necessary for regulation of mitochondrial
β-oxidation of fatty acids and for the development of hep-
atic steatosis [14]. Also, LA may reduce the acetylation
level of LCAD and then induce its enzymatic activity dir-
ectly through stimulation of SIRT3 [39,40]. On the other
hand, LA has been reported to decrease the mRNA levels
[14,41] and activities [41] of a series of enzymes involved
in hepatic fatty acid synthesis such as fatty acid synthase
and ATP-citrate lyase. Moreover, LA intake also inhibits
liver cholesterol synthesis by down-regulating the expres-
sion of genes for enzymes involved in cholesterol synthesis
[38].
High-fat diet reduces the levels of hepatic antioxidants,
which results in the remarkable increase in oxidative
stress and lipid peroxidation [42,43]. In the present
study, administration of FO + LA combination signifi-
cantly elevated the activities of antioxidant enzymes
SOD, CAT and GPx as well as level of GSH. The in-
creased antioxidant capability in liver combining with
the remarkable decline of hepatic TBARS levels meant
that FO + LA consumption significantly attenuated oxi-
dative stress in liver. Although FO might decrease the
depletion of hepatic GSH contents by lowering hepatic
cholesterol and triacylglycerol levels [8], the drastic hep-
atic oxidative stress improvement effect of FO + LA con-
sumption in this study should mainly attribute to the
antioxidant properties of LA. LA is an eight-carbon
structure that contains a disulfide bond as part of a
dithiolane ring, and this characteristic structure is re-
sponsible for the potent antioxidant activity of this mol-
ecule and its reduced form, dihydrolipoic acid (DHLA).
In fact, both LA and DHLA are capable of scavenging a
variety of free radicals and also chelating redox active
transition metals [10]. Far longer than its sole chemical
reduction and redox properties, LA may maintain hep-
atic low molecular weight antioxidants vitamin C and
GSH levels by inducing the uptake or enhancing the
synthesis [10]. Also, this molecule may act as a transient
but potent mediator of stress response signaling and
thus affects other important antioxidants [44]. For ex-
ample, LA can increase the activities of SOD and GPx in
liver of rats fed high fat diet through the stimulation of
SIRT1 and SIRT3 [40]. In addition, LA appears to be an
inducer of Nrf2-mediated antioxidant gene expression
[44,45], which significantly increases expression of the
antioxidant enzyme heme oxygenase-1 [15] and cellular
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aforementioned antioxidative mechanisms, LA plays a
critical role in determining antioxidative capacity of FO
and LA combination and may be mainly responsible for
the substantially improved hepatic oxidative stress in this
experiment.
Conclusions
In summary, substitution of lard with FO + LA reduced
triacylglycerol and cholesterol levels and elevated the
capacity of antioxidant defense in liver in a dose-
dependent manner, which meant that this combination
has the ability to reduce excessive hepatic fat accumula-
tion and oxidative stress. These results indicated that the
combination of FO + LA might contribute to ameliorate
nonalcoholic fatty liver induced by high-fat lard diet.
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